Trevi Therapeutics Inc.
Organization details
- Legal name
- Trevi Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New Haven
- Headquarters state / province
- Connecticut
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TRVI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001563880
- EIN
- 45-0834299
Board of directors
-
Anne Vanlent · DirectorSince 2023
-
David P. Meeker · DirectorSince 2023
-
Dominick Colangelo · DirectorSince 2023
- Since 2023
-
James Cassella V · DirectorSince 2023
-
Jennifer L. Good · Director · President & CEOSince 2023
- Since 2023
Chief executives
Director election results
Annual meeting of June 11, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.5%
-
99.7%
Board connections
5 of this board's directors also sit on 11 other boards. 11 are in the same sector.
-
Rhythm Pharmaceuticals Inc. Same sectorvia David P. Meeker, Edward T. Mathers and Jennifer L. Good
-
Avalo Therapeutics Inc. Same sectorvia Michael Thomas Heffernan
-
Biohaven Ltd. Same sectorvia Michael Thomas Heffernan
-
Collegium Pharmaceutical Inc. Same sectorvia Michael Thomas Heffernan
-
Kardigan Inc. Same sectorvia David P. Meeker
-
MBX Biosciences Inc. Same sectorvia Edward T. Mathers
-
OnKure Therapeutics Inc. Same sectorvia Edward T. Mathers
-
Pharvaris N.V. Same sectorvia David P. Meeker
-
Senti Biosciences Holdings Inc. Same sectorvia Edward T. Mathers
-
Vericel Corporation Same sectorvia Dominick Colangelo
-
enGene Therapeutics Inc. Same sectorvia Michael Thomas Heffernan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $595,806
- 4 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Michael Thomas Heffernan Director | Option exercise | +18,421 | $3.04 | $56,000 |
| Sep 15, 2026 | Michael Thomas Heffernan Director | Open-market sale | −18,321 | $15.09 | $276,464 |
| Sep 15, 2026 | Michael Thomas Heffernan Director | Open-market sale | −100 | $15.88 | $1,588 |
| Sep 15, 2026 | Michael Thomas Heffernan Director | Option exercise | +21,052 | $3.33 | $70,103 |
| Sep 15, 2026 | Michael Thomas Heffernan Director | Open-market sale | −20,952 | $15.09 | $316,166 |
| Sep 15, 2026 | Michael Thomas Heffernan Director | Open-market sale | −100 | $15.88 | $1,588 |
| Dec 2, 2025 | Galletta Christopher Officer (See Remarks) | Option exercise | +4,225 | $0.51 | $2,155 |
| Apr 17, 2025 | Scott D. Sandell 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | Ali Behbahani 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | NEA Partners 16, L.P. 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | Florence Anthony A. Jr. 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | BASKETT FOREST 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | Makhzoumi Mohamad 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | Walker Paul Edward 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Apr 17, 2025 | Carmen Chang 10% owner | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Trevi Therapeutics Inc.
Who is the CEO of Trevi Therapeutics Inc.?
Jennifer L. Good is Trevi Therapeutics Inc.'s President & CEO.
How many directors are on Trevi Therapeutics Inc.'s board?
Trevi Therapeutics Inc.'s board has 7 directors: Anne Vanlent, David P. Meeker, Dominick Colangelo, Edward T. Mathers, James Cassella V, Jennifer L. Good and Michael Thomas Heffernan.
Are Trevi Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Trevi Therapeutics Inc. insiders made no open-market purchases and sold $595,806 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="trevi-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.